From
StayCurrentMD
Pediatric and Young Adult Image-Guided Percutaneous Bone Biopsy-A New Standard of Care?
hosted by Dr. Sophia Schermerhorn
Chapter 1 of 1 · Evidence & Research
Image-Guided Percutaneous Biopsy for Pediatric Bone Tumors
Cued at 0:33 · press play
Expert statements on this page
No expert statements were drawn from this page.
Host summaries · secondary, not cited in answers
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Podcast
Diaphragm pacing as alternative to mechanical ventilation in pediatric respiratory failure
1 min · Published Nov 2026
Podcast
Fetoscopic endoluminal tracheal occlusion for congenital diaphragmatic hernia
4 min · Published Nov 2026
Podcast
FETO procedure for late-diagnosed severe CDH with liver herniation
4 min · Published Nov 2026
Podcast
Severe CDH case with FETO: unexpected anatomic findings and clinical outcome
3 min · Published Nov 2026
Podcast
Pediatric pancreatitis: diagnosis, causes, and genetic insights with Dr. Juan Gurria
3 min · Published Nov 2026
Podcast
Understanding craniosynostosis: skull sutures, growth patterns, and diagnosis in infants
10 min · Published Nov 2026
What the experts said
The study evaluated 169 biopsies in 141 patients over a 10-year period at a single institution.
Nearly 90% of the biopsies were core-needle biopsies.
All biopsies were performed with image guidance, most commonly CT, sometimes combined with fluoroscopy and ultrasound.
All biopsies were performed by interventional radiologists.
97.9% of biopsies were diagnostic.
Only 3 patients required repeat biopsy.
There was one patient with transient sciatic nerve paresis, which resolved.
The complication rate was 0.7%.
The approach provided sufficient tissue for histology, immunostains, and molecular studies.
Immunostains and molecular studies are increasingly essential for modern risk stratification and targeted therapy.
Image-guided percutaneous biopsy should be strongly considered the diagnostic modality of choice for pediatric bone and soft tissue tumors.